An innovative service company focusing on the field of drug quality control


Contact Us

You are here:Home >> News >> Company News

Company News

Bortezomib Impurities - SZEB

Time:2023-01-13 Views:2
Bortezomib is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.This includes multiple myeloma in those who have and have not previously received treatment.
Bortezomib was approved for medical use in the United States in 2003 and in the European Union in 2004. It is on the World Health Organization‘s List of Essential Medicines.It is available as a generic medication.
We manufacture and furnish high quality Bortezomib impurity for global markets. More information is available on the official website: If you have any questions, please send an email to We are looking forward to cooperating with you.
The following are some of the impurities of Bortezomib:
  • Previous:Nothing
  • Next:Etoricoxib Impurities - SZEB  2023/01/05